Ackerman Cancer Center Celebrates
2,000 Patients Treated with Proton Therapy
March 31st, 2022
Jacksonville, FL – Ackerman Cancer Center, the world’s first and only physician-owned proton therapy center, has reached a significant milestone in cancer care with the treatment of their 2,000th proton therapy patient, achieving the most time efficient per-room ramp-up for an independent proton therapy center worldwide.
Since treating their first proton therapy patient in April of 2015, the goal of Ackerman Cancer Center’s Proton Therapy Center has been to provide patients access to the most advanced and precise radiation therapy available.
Ackerman Cancer Center’s patient centric approach to treatment is unique and sets them apart from other cancer institutions. “Being independent allows us to reduce time to treatment as well as remove any barriers patients have, allowing them to get treated quickly- every day with cancer counts. Our patient care team of physicians, oncology nurses, dietitians, social workers, psychologists and therapists work with every patient to understand their unique needs. If a patient has a barrier to care, the entire team works collaboratively to ensure those barriers are eliminated and exceptional care is delivered.” – Dr. Scot Ackerman, Medical Director of Ackerman Cancer Center.
Ackerman Cancer Center will honor our 2000th proton therapy patient, Mrs. Shosh Orgad, a 70-year-old woman diagnosed with breast cancer who is traveling from Boca Raton, FL for proton therapy, along with her spouse, Mr. Izhak Orgad, who was treated for prostate cancer in 2020 on the same proton beam machine Mrs. Orgad has received treatment.
“When I first came to Ackerman Cancer Center, I knew I was at the right place. When Shosh was diagnosed with breast cancer, I called the team right away.” – Mr. Orgad.
Ackerman Cancer Center reached their one 1,000 proton therapy patient milestone in October of 2018, and has continued to lead the proton therapy community as the most time efficient per-room room growth in the history of Mevion Medical Systems. They are able to safely and effectively treat a diverse set of cancers with proton therapy including head and neck, lung, breast, and prostate, among others.
For media inquiries, please reach out to Ryan Ali (Director of Community Relations and Ackerman Cancer Foundation)
Phone: (904)880-5522
Email: acccr@ackermancancer.com